Lineage Cell Therapeutics
LCTX
$1.05
Share price
-7.08%
Change (1 day)
-22.79%
Change (1 year)
Categories
Earnings for Lineage Cell Therapeutics (LCTX)
Earnings in 2023 (TTM): -$24.74 M
According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings (TTM) are -$24.74 M. a decrease over its 2022 earnings that were of -$22.52 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lineage Cell Therapeutics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$24.74 M | 9.83% |
| 2022 | -$22.52 M | -54.24% |
| 2021 | -$49.22 M | 86.07% |
| 2020 | -$26.45 M | -31.97% |
| 2019 | -$38.88 M | -5.42% |
| 2018 | -$41.11 M | 1.1% |
| 2017 | -$40.66 M | -31.06% |
| 2016 | -$58.97 M | -10.38% |
| 2015 | -$65.81 M | 29.69% |
| 2014 | -$50.74 M | 31.68% |
| 2013 | -$38.54 M | |
| 2011 | -$18.7 M | 89.78% |
| 2010 | -$9.86 M | 206.06% |
| 2009 | -$3.22 M | -0.58% |
| 2008 | -$3.24 M | 164.89% |
| 2007 | -$1.23 M | -30.22% |
| 2006 | -$1.76 M | |
| 2002 | -$2.04 M | -41.04% |
| 2001 | -$3.46 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 347.90% | 🇺🇸 USA |